Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Benjamin Miron, Jean Hoffman‐Censits, Fern Anari, John P. O’Neill, Daniel M. Geynisman, Matthew R. Zibelman, Alexander Kutikov, Rosalia Viterbo, Richard E. Greenberg, David Chen, Costas D. Lallas, Edouard J. Trabulsi, R. Katherine Alpaugh, Essel Dulaimi, Erica A. Golemis, Robert G. Uzzo, Eric A. Ross, Elizabeth R. Plimack
Topics & Concepts
MedicineCisplatinBladder cancerChemotherapyOncologyDNA repairNeoadjuvant therapyCancerCancer researchInternal medicineGeneBioinformaticsGeneticsBiologyBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesEsophageal Cancer Research and Treatment